What are the diagnostic and therapeutic approaches to myxedema coma?

• A. Oral levothyroxine with hydration
• B. Observation and warming only
• C. Administration of IV liothyronine alone
• D. Hypothermia with mental status depression; treat with IV levothyroxine, hydrocortisone if adrenal insufficiency suspected, airway support, warming, and fluids

Answer: (D)

Myxedema coma is a medical emergency from severe hypothyroidism, so the priority is rapid stabilization and definitive thyroid hormone replacement along with supportive care and assessment for adrenal insufficiency. Diagnosis is clinical, supported by labs such as very low free T4 (TSH patterns vary with cause), low or inappropriately normal cortisol if adrenal insufficiency is possible, and common abnormalities like hyponatremia or hypoglycemia, but treatment should not wait for laboratory confirmation.

Begin with securing the airway and ensuring adequate breathing and circulation. Intubation and ventilation may be necessary for altered mental status or hypoventilation, and continuous cardiac monitoring is important due to bradycardia and potential arrhythmias. Address warming and circulation with gradual rewarming and careful IV fluids to avoid rapid shifts in hemodynamics. Administer thyroid hormone parenterally because oral absorption can be unreliable in this crisis; the preferred approach is intravenous levothyroxine given as a loading dose (typically 200-400 mcg) followed by a maintenance IV dose (often 50-100 mcg daily). In some protocols, low-dose IV liothyronine (T3) is added for a more rapid effect, but many guidelines favor levothyroxine alone unless the patient is profoundly ill or not responding, due to safety considerations. Importantly, give hydrocortisone empirically if adrenal insufficiency is suspected or cannot be rapidly excluded (for example, 100 mg IV every 8 hours) to prevent adrenal crisis while evaluating the axis. Correct hypoglycemia if present, and address electrolyte disturbances and any precipitating factor such as infection. The overall plan continues with ongoing thyroid hormone replacement, supportive care, and treatment of the underlying cause until the patient is stabilized and thyroid function improves.